733
edits
Myocardial Disease: Difference between revisions
→Arrythmic cardiomyopathy: Arrhythmogenic Right Ventricular Cardiomyopathy
| Line 628: | Line 628: | ||
† A pathogenic mutation is a DNA alteration associated with ARVC/D that alters or is expected to alter the encoded protein, is unobserved or rare in a large non–ARVC/D control population, and either alters or is predicted to alter the structure or function of the protein or has demonstrated linkage to the disease phenotype in a conclusive pedigree. E.g.: in TMEM43, DSP, PKP2, DSG2, DSC2, JUP. | † A pathogenic mutation is a DNA alteration associated with ARVC/D that alters or is expected to alter the encoded protein, is unobserved or rare in a large non–ARVC/D control population, and either alters or is predicted to alter the structure or function of the protein or has demonstrated linkage to the disease phenotype in a conclusive pedigree. E.g.: in TMEM43, DSP, PKP2, DSG2, DSC2, JUP. | ||
|} | |} | ||
<gallery> | |||
Image:arvd_ecg1.png| a patient with ARVD | |||
Image:arvd_ecg2.png | |||
Image:arvd_ecg3.png | |||
</gallery> | |||
====Treatment==== | ====Treatment==== | ||
Treatment focuses on avoiding complications. | Treatment focuses on avoiding complications. | ||